Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J CEO Bill Weldon Has ‘No Plans’ To Retire Now
Pharmalot
Monday, March 21, 2011 - 11:41am
tags:
Pharma CEOs, William Weldon, JNJ
DSM Likely Interested in Pfizer Nutrition Unit, Cheuvreux Says
Bloomberg
Monday, March 21, 2011 - 11:35am
tags:
Royal DSM, Pfizer, M&A
Shire advances rival to Dyax drug
Bizjournals.com
Monday, March 21, 2011 - 11:34am
tags:
Shire, Dyax, hereditary angiodema, Kalbitor, Firazyr
XenoPort announces mid-stage drug study result
Yahoo/AP
Monday, March 21, 2011 - 11:32am
tags:
XenoPort, arbaclofen placarbil, heartburn
Why InterMune's Earnings Aren't So Hot
Motley Fool
Monday, March 21, 2011 - 11:31am
tags:
earnings, InterMune
Roche, Curis Skin Cancer Drug Advances
TheStreet.com
Monday, March 21, 2011 - 11:25am
tags:
skin cancer, Roche, Curis
Ariad Pharmaceuticals: Solid Company but Not a Steal
Seeking Alpha
Monday, March 21, 2011 - 11:24am
tags:
Ariad Pharmaceuticals
Depomed's Recent Events Boost Balance Sheet
Seeking Alpha
Monday, March 21, 2011 - 11:21am
tags:
Depomed, Abbott Laboratories, Gralise, Glumetza
Novartis gets EU approval for oral MS drug
Yahoo/AP
Monday, March 21, 2011 - 11:19am
tags:
Europe, MS, Novartis, multiple sclerosis
To improve drug safety, FDA should check its mixed-up files
Boston Globe, MA
Sunday, March 20, 2011 - 11:33am
tags:
FDA
Klobuchar wants KV drug investigation
bizjournals.com
Sunday, March 20, 2011 - 11:28am
tags:
KV Pharmaceutical, Makena
The Next Big Thing In Biotech: Bristol-Myers (video)
The Street
Sunday, March 20, 2011 - 11:17am
tags:
Bristol-Myers Squibb
Eli Lilly "very much opposed" to merger: CEO
Yahoo/Reuters
Saturday, March 19, 2011 - 11:30am
tags:
Eli Lilly, M&A
Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Bradenton Herald, FL
Saturday, March 19, 2011 - 11:00am
tags:
Panitumumab, colorectal cancer, Amgen, Vectibix
Cortex Pharmaceuticals (CORX.OB) Shares Surge on Q4, FY2010 Results, Recent Business Highlights Read more: http://www.ibtimes.com/articles/124529/20110318/cortex-pharmaceuticals-corx-ob-shares-surge-on-q4-fy2010-results-recent-business-highlights.htm#i
International Business Times
Saturday, March 19, 2011 - 10:58am
tags:
Cortex Pharmaceuticals
J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug
Bloomberg
Saturday, March 19, 2011 - 10:50am
tags:
JNJ, Teva Pharmaceuticals, Prezista, HIV
GlaxoSmithKline donates $2.5M to Japan relief
bizjournals.com
Saturday, March 19, 2011 - 10:49am
tags:
GSK
West Pharmaceutical Services Inc. (WST) Posts Large Volume Increase, Hits $41.96
American Banking News
Saturday, March 19, 2011 - 10:47am
tags:
West Pharmaceutical
Novalar Announces Acquisition of OraVerse® by Septodont
PR NewsWire
Saturday, March 19, 2011 - 10:46am
tags:
Novalar, OraVerse, Septodont, local anesthesia reversal agent
Don't Miss This Buffett-Type Business
Motley Fool
Saturday, March 19, 2011 - 10:42am
tags:
Mead Johnson Nutrition, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.